Latest Insider Transactions at Integra Lifesciences Holdings Corp (IART)
This section provides a real-time view of insider transactions for Integra Lifesciences Holdings Corp (IART). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTEGRA LIFESCIENCES HOLDINGS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTEGRA LIFESCIENCES HOLDINGS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 09
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Open market or private sale
|
Direct |
1,177
-4.78%
|
$51,788
$44.46 P/Share
|
|
Jul 03
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,196
+33.11%
|
-
|
|
Jul 03
2023
|
Lea Daniels Knight EVP & CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
24,391
+35.0%
|
-
|
|
Jun 01
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Open market or private purchase
|
Direct |
2,640
+5.15%
|
$97,680
$37.89 P/Share
|
|
Jun 01
2023
|
Jan De Witte President & CEO |
BUY
Open market or private purchase
|
Direct |
7,792
+37.84%
|
$296,096
$38.5 P/Share
|
|
May 13
2023
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
185
-0.15%
|
$9,065
$49.05 P/Share
|
|
May 12
2023
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,302
+4.09%
|
-
|
|
May 12
2023
|
Shaundra Clay Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,486
+25.33%
|
-
|
|
May 12
2023
|
Barbara B Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,117
+3.37%
|
-
|
|
May 12
2023
|
Raymond G. Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,486
+9.01%
|
-
|
|
May 12
2023
|
Renee Wonlai Lo Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,486
+37.57%
|
-
|
|
May 12
2023
|
Christian S Schade Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,486
+7.57%
|
-
|
|
May 12
2023
|
Stuart Essig Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
5,505
+0.48%
|
-
|
|
Mar 13
2023
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,469
-1.56%
|
$76,388
$52.61 P/Share
|
|
Mar 13
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-0.81%
|
$10,608
$52.61 P/Share
|
|
Mar 13
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,331
-1.42%
|
$75,867
$57.61 P/Share
|
|
Mar 13
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-1.1%
|
$49,556
$52.61 P/Share
|
|
Mar 13
2023
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-2.5%
|
$49,868
$52.61 P/Share
|
|
Mar 12
2023
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,637
-1.13%
|
$85,124
$52.87 P/Share
|
|
Mar 12
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-0.76%
|
$15,132
$52.87 P/Share
|
|
Mar 12
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,170
-0.81%
|
$60,840
$52.87 P/Share
|
|
Mar 12
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,629
-1.22%
|
$84,708
$52.87 P/Share
|
|
Mar 12
2023
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
972
-1.62%
|
$50,544
$52.87 P/Share
|
|
Mar 11
2023
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,842
-43.42%
|
$199,784
$52.87 P/Share
|
|
Mar 11
2023
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,257
-1.26%
|
$65,364
$52.87 P/Share
|
|
Mar 11
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
243
-0.93%
|
$12,636
$52.87 P/Share
|
|
Mar 11
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
3,764
-3.67%
|
$195,728
$52.87 P/Share
|
|
Mar 11
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,348
-1.46%
|
$70,096
$52.87 P/Share
|
|
Mar 11
2023
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
760
-1.81%
|
$39,520
$52.87 P/Share
|
|
Mar 10
2023
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
4,227
+7.77%
|
-
|
|
Mar 10
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+11.01%
|
-
|
|
Mar 10
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
5,070
+8.85%
|
-
|
|
Mar 10
2023
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
17,586
+17.37%
|
-
|
|
Mar 10
2023
|
Lisa Evoli EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,532
+10.7%
|
-
|
|
Mar 07
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Open market or private sale
|
Direct |
1,843
-6.02%
|
$99,522
$54.29 P/Share
|
|
Mar 02
2023
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
723
-2.31%
|
$39,765
$55.09 P/Share
|
|
Mar 01
2023
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Open market or private sale
|
Direct |
1,566
-3.3%
|
$86,130
$55.21 P/Share
|
|
Mar 01
2023
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,566
+3.19%
|
$40,716
$26.86 P/Share
|
|
Feb 27
2023
|
Lisa Evoli EVP & CHRO |
SELL
Open market or private sale
|
Direct |
3,767
-16.84%
|
$214,719
$57.0 P/Share
|
|
Feb 13
2023
|
Jan De Witte President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,848
+50.0%
|
-
|
|
Feb 13
2023
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
9,757
+5.12%
|
-
|
|
Feb 13
2023
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
7,108
+3.94%
|
-
|
|
Feb 13
2023
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
6,073
+4.97%
|
-
|
|
Feb 13
2023
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,537
+3.87%
|
-
|
|
Feb 13
2023
|
Lisa Evoli EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+4.99%
|
-
|
|
Jan 18
2023
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
431
-100.0%
|
$23,274
$54.78 P/Share
|
|
Jan 18
2023
|
Jan De Witte President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
431
+50.0%
|
-
|
|
Dec 08
2022
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Open market or private sale
|
Direct |
279
-3.16%
|
$15,624
$56.22 P/Share
|
|
Aug 10
2022
|
Lisa Evoli EVP & CHRO |
SELL
Open market or private sale
|
Direct |
1,165
-6.08%
|
$64,075
$55.81 P/Share
|
|
Aug 05
2022
|
Raymond G. Murphy Director |
SELL
Open market or private sale
|
Direct |
8,000
-16.39%
|
$440,000
$55.78 P/Share
|